Business Name: |
Reclaim Pharmaceutical Waste Management |
Contact Person: |
Todd Johnson |
Address: |
3740 East Bluebird Lane, Bloomington, Indiana 47401 |
Phone Number: |
No number given |
Annual Revenue (USD): |
$50.000 to $99.999 |
Founding Year: |
2010 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2B (Business to Business) |
Business Category: |
Management Services |
SIC Code: |
8741 |
NAICS Code: |
561110 |
Share This Business: |
|
Related Businesses: |
Keynote Data Management - Bloomington, IN 47401 Mclary Management - Bloomington, IN 47401 Empirian Property Management - Bloomington, IN 47401 Subway - Bloomington, IN 47401 Pepper Construction - Bloomington, IN 47401 Sesom Management Inc - Bloomington, IN 47401 Hane Management Services Inc - Bloomington, IN 47401 Pro-Telligent LLC - Bloomington, IN 47401 Rosedale Property Management LLC - Bloomington, IN 47401 Sigma Property Management LLC - Bloomington, IN 47401 Anders Property Management L L C - Bloomington, IN 47401 Cameron Management LLC - Bloomington, IN 47401 Place Management Group LLC - Bloomington, IN 47401 Regency Management Service - Bloomington, IN 47401 D & D Management Group Inc - Bloomington, IN 47401 |
The company Reclaim Pharmaceutical Waste Management provides B2B services in the form of Management Services from its single location in Indiana.
1 to 4 employees work for Reclaim Pharmaceutical Waste Management, and the business now earns $50.000 to $99.999 per annum.
Reclaim Pharmaceutical Waste Management was launched in 2010 and is classified under SIC code and category 8741 , and NAICS number and grouping 561110 .
To contact Reclaim Pharmaceutical Waste Management, please call Todd Johnson with the phone number No number given or visit its single location at 3740 East Bluebird Lane in Bloomington, Indiana 47401.
The location of the single location can also be found using the coordinates 39.130335,-86.483955.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.